Ad is loading...
DNLI
Price
$24.87
Change
+$1.55 (+6.65%)
Updated
Dec 6, 04:59 PM (EDT)
85 days until earnings call
RCKT
Price
$13.88
Change
+$0.56 (+4.20%)
Updated
Dec 6, 04:59 PM (EDT)
88 days until earnings call
Ad is loading...

DNLI vs RCKT

Header iconDNLI vs RCKT Comparison
Open Charts DNLI vs RCKTBanner chart's image
Denali Therapeutics
Price$24.87
Change+$1.55 (+6.65%)
Volume$11.44K
CapitalizationN/A
Rocket Pharmaceuticals
Price$13.88
Change+$0.56 (+4.20%)
Volume$9.25K
CapitalizationN/A
DNLI vs RCKT Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DNLI vs. RCKT commentary
Dec 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Sell and RCKT is a StrongBuy.

COMPARISON
Comparison
Dec 08, 2024
Stock price -- (DNLI: $24.89 vs. RCKT: $13.89)
Brand notoriety: DNLI and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 66% vs. RCKT: 78%
Market capitalization -- DNLI: $3.36B vs. RCKT: $1.21B
DNLI [@Biotechnology] is valued at $3.36B. RCKT’s [@Biotechnology] market capitalization is $1.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, RCKT is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 6 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • RCKT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -0.44% price change this week, while RCKT (@Biotechnology) price change was -3.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.36B) has a higher market cap than RCKT($1.21B). DNLI YTD gains are higher at: 15.983 vs. RCKT (-53.654). RCKT has higher annual earnings (EBITDA): -247.25M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. RCKT (236M). RCKT has less debt than DNLI: RCKT (25.6M) vs DNLI (52.5M). DNLI (0) and RCKT (0) have equivalent revenues.
DNLIRCKTDNLI / RCKT
Capitalization3.36B1.21B276%
EBITDA-496.05M-247.25M201%
Gain YTD15.983-53.654-30%
P/E RatioN/AN/A-
Revenue00-
Total Cash837M236M355%
Total Debt52.5M25.6M205%
FUNDAMENTALS RATINGS
DNLI vs RCKT: Fundamental Ratings
DNLI
RCKT
OUTLOOK RATING
1..100
626
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
5689
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (43) in the Biotechnology industry is somewhat better than the same rating for DNLI (94). This means that RCKT’s stock grew somewhat faster than DNLI’s over the last 12 months.

DNLI's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as RCKT (100). This means that DNLI’s stock grew similarly to RCKT’s over the last 12 months.

DNLI's SMR Rating (95) in the Biotechnology industry is in the same range as RCKT (97). This means that DNLI’s stock grew similarly to RCKT’s over the last 12 months.

DNLI's Price Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for RCKT (89). This means that DNLI’s stock grew somewhat faster than RCKT’s over the last 12 months.

DNLI's P/E Growth Rating (99) in the Biotechnology industry is in the same range as RCKT (100). This means that DNLI’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLIRCKT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 18 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
INPIX60.101.37
+2.33%
ProFunds Internet UltraSector Inv
RIBEX63.430.33
+0.52%
American Funds Invmt Co of Amer R2E
RRRZX23.340.01
+0.04%
DWS RREEF Real Estate Securities R6
FCVFX38.20-0.22
-0.57%
Fidelity Advisor Value C
JDWNX112.62-8.02
-6.65%
Janus Henderson Global Research N

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+6.73%
BEAM - DNLI
65%
Loosely correlated
+5.49%
JANX - DNLI
55%
Loosely correlated
-1.98%
NTLA - DNLI
55%
Loosely correlated
+7.84%
LGND - DNLI
54%
Loosely correlated
+1.07%
RCKT - DNLI
53%
Loosely correlated
+4.28%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+4.28%
DNLI - RCKT
53%
Loosely correlated
+6.73%
NTLA - RCKT
53%
Loosely correlated
+7.84%
AXON - RCKT
52%
Loosely correlated
-0.30%
FATE - RCKT
52%
Loosely correlated
+11.34%
PRME - RCKT
51%
Loosely correlated
+10.10%
More